Home
Modeling and Simulation to Select Oncology Dosages - Session 2
U.S. Food and Drug Administration
10 พ.ค. 2024
การดู 641 ครั้ง
Modeling and Simulation to Select Oncology Dosages - Session 3
Modeling and Simulation to Select Oncology Dosages - Session 1
Facilitating Generic Drug Product Development through Product-Specific Guidances
Osteoporosis: A Perspective for 2024
Statistical Considerations for Premarketing Risk Assessment
Redesigned Pre-Submission Meetings in GDUFA III: Benefits for ANDA Submission and Approval
May 22, 2024 Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee
125th Meeting of the Blood Products Advisory Committee (BPAC)
REdI Annual Conference 2024: CBER (Biologics) Innovation in Medical Product Development (Day 1 of 2)
REdI Annual Conference 2024: CDRH (Devices) Innovation in Medical Product Development (Day 1 of 2)
REdI Annual Conference 2024: CDER (Drugs) Innovation in Medical Product Development (Day 1 of 2)
May 24, 2024 Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) Meeting
The Future of Clinical Trials, The Real Cost Campaign, and Sun Safety Tips | FDA In Your Day Ep. 5
Waterproof Sunscreen? Sun Safety Tips from Episode 5 of FDA In Your Day | Full Video on Channel
Can Cardiac "Organ on a Chip" Technology Help Drug Toxicology Researchers? | Researching FDA
Can Cardiac "Organ on a Chip" Technology Help Drug Toxicology Researchers? (Full Video on Channel)
An MOUD Success Story from Dr. Matthew Hahn
Prescribe with Confidence: Dr. Califf introduces FDA’s MOUD campaign for health care professionals
Dr. Matthew Hahn on Treating OUD with Medication
REdI Annual Conference 2024: CDRH (Devices) Innovation in Medical Product Development (Day 2 of 2)